Back

RESEARCH PLATFORM 1

R.P 1.2 Anti-Myopia Electronic Displays: Making Screens Eye-Safe for Children

DOWNLOAD POSTER

Principle Investigators

PolyU

Prof. Ka-man Rachel CHUN

Prof. Yan-yin Dennis TSE

UWaterloo

Prof. Deborah JONES

Prof. Ben THOMPSON

Co-I

Dr. Elie de LESTRANGE-ANGINIEUR

Prof. Chi-ho TO

Dr. Vivian CHOH

Aims

RP1.2 aims to make digital-device screens that are eye-safe for children by counteracting the screen-based signals that contribute to the onset and progression of myopia.

Background

The project foundation lies in the groundbreaking design of anti-myopia lenses that were developed within the PolyU School of Optometry. These lenses blur peripheral (side) vision in a way that significantly reduces the progression of myopia. Specifically, the lenses focus peripheral images in front of the retina causing what is called myopic blur. The patented technology is now being used in over 20 countries, benefiting over 2 million children worldwide.

Work to be Done

Develop two novel, parallel, and complementary technologies that will produce myopic blur when children use digital screens. One technology, simulated myopic defocus, utilizes eye tracking and image processing to therapeutically blur images in real time using only software. This approach will enable anti-myopia algorithms to be switched on and off through software on any device and will be marketed to the general public.

Benefits

Eye-safe screens will reduce myopia risk factors, directly benefiting children in dense urban environments with high digital screen use. Individuals will experience an enhanced quality of life due to the reduced severity of myopia, which not only improves personal well-being but also prevents high myopia-related ocular complications

Impact

Anti-myopia screens can significantly reduce the public health burden by decreasing the prevalence of high myopia and its associated ocular diseases, such as glaucoma and retinal detachment. This leads to a healthier, visually capable, and productive community, as individuals benefit from lifelong prevention of visual loss and maintain a good quality of life. Additionally, the economic burden from reduced work productivity and long-term healthcare costs is lowered, while the public health care system experiences less strain from myopia-related vision impairments.

Learn more about R.P 1.1 Learn more about R.P 1.3

R.P 1.1 Development and Clinical Validation of AI-Based Software as a Medical Device for Non-Invasive Ophthalmic Imaging and Automated Reporting

Development and Clinical Validation of AI-Based Software as a Medical Device for Non-Invasive Ophthalmic Imaging and Automated Reporting

R.P 1.2 Anti-Myopia Electronic Displays: Making Screens Eye-Safe for Children

Principle Investigators

Prof. Ka-man Rachel CHUN

Prof. Yan-yin Dennis TSE

Prof. Deborah JONES

Prof. Ben THOMPSON

Dr. Elie de LESTRANGE-ANGINIEUR

Prof. Chi-ho TO

Dr. Vivian CHOH

Aims

Background

Work to be Done

Benefits

Impact

Learn More About Other Research Projects

R.P 1.1 Development and Clinical Validation of AI-Based Software as a Medical Device for Non-Invasive Ophthalmic Imaging and Automated Reporting

R.P 1.3 Advanced Technologies for Prediction of Myopia Progression

R.P 1.4 Targeting Higher-Level Brain Functions for Amblyopia Rehabilitation

R.P 1.5 Novel Neuromodulation Approaches for Vision Enhancement in Adults

R.P 2.1 Clinical Translation of a Novel Anti-Microbial Therapy for Eye Infections

R.P 2.2 An Organoid Platform and Cell-Based Platform for Ocular Therapeutic Development

R.P 2.3 Developing Next-Generation Therapeutic Agents for Glaucoma

R.P 2.4 Novel Gene Delivery Platforms for the Treatment of Ocular Disease

R.P 2.5 Integrated Dry Eye Diagnosis and Precision Therapies

R.P 2.6 Development of Ocular Inserts and Aptamer-Based Delivery Vehicles for Sustained Release of Ocular Therapeutics and TCM Products

R.P 3.1 Eye Disease Diagnosis and Treatment Enabled by Novel Retinal Instrumentation

R.P 3.2 Non-Invasive Tear-Based Diagnostic System

R.P 3.3 Development of New-Generation Contact Lenses Using Novel Materials and Additive Manufacturing

R.P 3.4 Detection of Macular Degeneration and Myopia-Induced Retinal Damage Using Structured Light Technology

R.P 3.5 Extended Reality Visual Intelligence System (XRVIS) for Tele-Visual Assessment and Safety Enhancement for People with Visual Impairment